Cargando…
Ulinastatin Reduces Cancer Recurrence after Resection of Hepatic Metastases from Colon Cancer by Inhibiting MMP-9 Activation via the Antifibrinolytic Pathway
High recurrence of colon cancer liver metastasis is observed in patients after hepatic surgery, and the cause is believed to be mostly due to the growth of residual microscopic metastatic lesions within the residual liver. Therefore, triggering the progression of occult metastatic foci may be a nove...
Autores principales: | Xu, Bo, Li, Kun-ping, Shen, Fei, Xiao, Huan-qing, Cai, Wen-song, Li, Jiang-lin, Liu, Qi-cai, Jia, Lin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3655446/ https://www.ncbi.nlm.nih.gov/pubmed/23710449 http://dx.doi.org/10.1155/2013/437950 |
Ejemplares similares
-
Synergism from the combination of ulinastatin and curcumin offers greater inhibition against colorectal cancer liver metastases via modulating matrix metalloproteinase-9 and E-cadherin expression
por: Shen, Fei, et al.
Publicado: (2014) -
Associations of MMP-2 and MMP-9 gene polymorphism with ulinastatin efficacy in patients with severe acute pancreatitis
por: Zhen, Guo-Dong, et al.
Publicado: (2017) -
Antifibrinolytics
por: Székely, A, et al.
Publicado: (2014) -
MMP-2 and MMP-9 gene polymorphisms act as biological indicators for ulinastatin efficacy in patients with severe acute pancreatitis
por: Ling, Lan, et al.
Publicado: (2019) -
Antifibrinolytics in liver surgery
por: Makwana, Jalpa, et al.
Publicado: (2010)